Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis

Journal of the American Society of Nephrology

Volumn 22, Issue 5, 2011, Pages 839-848

  Bell, P Darwin ^a,b   Fitzgibbon, Wayne ^b   Sas, Kelli ^b   Stenbit, Antine E ^b   Amria, May ^b   Houston, Amber ^b   Reichert, Ryan ^b   Gilley, Sandra ^b   Siegal, Gene P ^c   Bissler, John ^d   Bilgen, Mehmet ^e   Chou, Peter Cheng Te ^e   Guay Woodford, Lisa ^c   Yoder, Brad ^c   Haycraft, Courtney J ^b   Siroky, Brian ^d  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE; HISTOPATHOLOGY; IFT88 GENE; KIDNEY CELL; KIDNEY CILIA; KIDNEY CYST; KIDNEY DEVELOPMENT; KIDNEY DYSFUNCTION; KIDNEY HYPERTROPHY; KIDNEY TUBULE CELL; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79955631885     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010050526     Document Type: Article

References (40)

1. Guay-Woodford LM: Murine models of polycystic kidney disease: Molecular and therapeutic insights. Am J Physiol Renal Physiol 285: F1034-F1049, 2003
2. Siroky BJ, Guay-Woodford LM: Renal cystic disease: The role of the primary cilium/centrosome complex in pathogenesis. Adv Chronic Kidney Dis 13: 131-137, 2006
3. Zhou J: Polycystins and primary cilia: Primers for cell cycle progression. Annu Rev Physiol 71: 83-113, 2009
4. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease: The last 3 years. Kidney Int 76: 149-168, 2009
5. Cardenas-Rodriguez M, Badano JL: Ciliary biology: Understanding the cellular and genetic basis of human ciliopathies. Am J Med Genet C Semin Med Genet 151: 263-280, 2009
6. Takakura A, Contrino L, Beck AW, Zhou J: Pkd1 inactivation induced in adulthood produces focal cystic disease. J Am Soc Nephrol 19: 2351-2363, 2008
7. Davenport JR, Watts AJ, Roper VC, Croyle MJ, van Groen T, Wyss JM, Nagy TR, Kesterson RA, Yoder BK: Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr Biol 17: 1586-1594, 2007 (Pubitemid 47380400)
8. Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A, Breuning MH, de Heer E, Peters DJ: Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum Mol Genet 16: 3188-3196, 2007 (Pubitemid 350131335)
9. Patel V, Li L, Covo-Stark P, Shao X, Somlo S, Lin F, Igarashi P: Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum Mol Genet 17: 1578-1590, 2008 (Pubitemid 351737162)
10. Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG: A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 13: 1490-1495, 2007 (Pubitemid 350224245)
11. Churchill M, Churchill PC, Schwartz M, Bidani A, McDonald F: Reversible compensatory hypertrophy in transplanted brown Norway rat kidneys. Kidney Int 40: 13-20, 1991
12. Schwartz MM, Churchill M, Bidani A, Churchill PC: Reversible compensatory hypertrophy in rat kidneys: Morphometric characterization. Kidney Int 43: 610-614, 1993 (Pubitemid 23071944)
13. Fleck C, Braunlich H: Kidney function after unilateral nephrectomy. Exp Pathol 25: 3-18, 1984 (Pubitemid 14195162)
14. Fine LG, Norman J: Cellular events in renal hypertrophy. Annu Rev Physiol 51: 19-32, 1989 (Pubitemid 19088305)
15. Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, Peter DJ: Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet 18: 2532-2542, 2009
16. Takakura A, Contrino L, Zhou X, Bonventre JV, Sun Y, Humphreys BD, Zhou J: Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet 15: 2523-2531, 2009
17. Devarajan P: Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr 17: 193-199, 2005
18. Chen JK, Chen J, Thomas G, Kozma SC, Harris RC: S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 297: F585-F593, 2009
19. Chen JK, Chen J, Neilson EG, Harris RC: Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol 16: 1384-1391, 2005 (Pubitemid 41716522)
20. Lieberthal W, Levine JS: The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol 20: 2493-2502, 2009
21. Siroky BJ, Bitzer M: The growing importance of mTORC1-S6K1 signaling in kidney. Am J Physiol Renal Physiol 297: F583-F584, 2009
22. Gibbons JJ, Abraham RT, Yu K: Mammalian target of rapamycin: Discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. Semin Oncol 36[Suppl 3]: S3-S17, 2009
23. Mostov KE: mTOR is out of control in polycystic kidney disease. Proc Natl Acad Sci U S A 103: 5247-5248, 2006
24. Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A, Walz G, Piontek KB, Germino GG, Weimbs T: The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 103: 5466-5471, 2006
25. Shillingford JM, Piontek KB, Germino GG, Weimbs T: Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J Am Soc Nephrol 21: 489-497, 2010
26. Tao Y, Kim J, Schrier RW, Edelstein CL: Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 16: 46-51, 2005 (Pubitemid 43073155)
27. Haycraft CJ, Zhang Q, Song B, Jackson WS, Detloff PJ, Serra R, Yoder BK: Intraflagellar transport is essential for endochondral bone formation. Development 134: 307-316, 2007
28. Yoder BK, Hou X, Guay-Woodford LM: The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 13: 2508-2516, 2002
29. Zhou X Bao H, Takakura A Zhou J, Albert M, Sun Y: Polycystic kidney disease evaluation by magnetic resonance imaging in ischemia-reperfusion injured PKD1 knockout mouse model: Comparison of T2- weighted FSE and true-FISP. Invest Radiol 45: 24-28, 2010
30. Sharp CK, Bergman SM, Stockwin JM, Robbin ML, Galliani C, Guay- Woodford LM: Dominantly transmitted glomerulocystic kidney disease: A distinct genetic entity. J Am Soc Nephrol 8: 77-84, 1997
31. Bissler JJ, Siroky B, Yin H: Glomerulocystic kidney disease. Pediatr Nephrol 25: 2049-2056, 2010
32. Mrug M, Zhou J, Woo Y, Cui X, Szalai AJ, Novak J, Churchill GA, Guay- Woodford LM: Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int 73: 63-76, 2008 (Pubitemid 350273645)
33. Babic N, Huskic J, Nakas-Icindic E: Angiotensin converting enzyme activity in compensatory renal hypertrophy. Bosn J Basic Med Sci 7: 79-83, 2007
34. Cevikbas F Schaefer L, Uhlig P, Robenek H, Theilmeier G, Echtermeyer F, Bruckner P: Unilateral nephrectomy leads to up-regulation of syndecan- 2- and TGF-beta-mediated glomerulosclerosis in syndecan-4 deficient male mice. Matrix Biol 27: 42-52, 2008
35. Ozeki M, Nagasu H, Satoh M, Namikoshi T, Haruna Y, Tomita N, Sasaki T, Kashihara N: Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney. J Physiol Sci 59: 397-404, 2009
36. Furukawa K, Ninomiya I, Shimizu J, Wada T, Matsuura Y: Renal sympathetic nerve activity and the weight of the remaining kidney in unilateral nephrectomized rats. J Auton Nerv Syst 63: 91-100, 1997 (Pubitemid 27119845)
37. Blantz RC, Peterson OW, Thomson SC: Tubuloglomerular feedback responses to acute contralateral nephrectomy. Am J Physiol 260: F749-F756, 1991
38. Pollock CA, Bostrom TE, Dyne M, Gyory AZ, Field MJ: Tubular sodium handling and tubuloglomerular feedback in compensatory renal hypertrophy. Pflugers Arch 420: 159-166, 1992
39. Siroky BJ, Czyzyk-Krzeska MF, Bissler JJ: Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: Shared disease mechanisms? Nat Clin Pract Nephrol 5: 143-156, 2009
40. Weichhart T, Costantino G, Poglitsch M, Rosner M, Zeyda M, Stuhimeier KM, Kobe T, Stulnig TM, Hori WH, Hengstschiager M, Muller M, Saemann MD: The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29: 565-577, 2008